Lin Cheng
Impact in
- Oncology top 10%
- Viral-associated cancers and disorders
- Cancer Research top 10%
Papers in
-
- Natural product bioactivities and synthesis 5
- Bone Metabolism and Diseases 4
- RNA Research and Splicing 3
-
- Breast Cancer Treatment Studies 7
- Co-authors
- Qiang Ding (12 shared papers)Ellen Li (2 shared papers)Chun Lu (4 shared papers)Tiansong Xia (6 shared papers)Liang Shi (6 shared papers)Wenbin Zhou (6 shared papers)Yulan Zhu (7 shared papers)Yi Zeng (3 shared papers)
- Journals
- PLoS ONE (3 papers)Bioscience Reports (3 papers)BMC Cancer (2 papers)Frontiers in Pharmacology (2 papers)Cancer Management and Research (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lin Cheng
69 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 105
- Oncology 289
- Cancer Research 137
- Molecular Biology 605
- Virology 27
- Health, Toxicology and Mutagenesis 66
Countries citing papers authored by Lin Cheng
This map shows the geographic impact of Lin Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Cheng more than expected).
Fields of papers citing papers by Lin Cheng
This network shows the impact of papers produced by Lin Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Cheng. The network helps show where Lin Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 159 | |
| 2 | 2006 | 107 | |
| 3 | 1993 | 91 | |
| 4 | 2013 | 87 | |
| 5 | 1994 | 74 | |
| 6 | 2021 | 65 | |
| 7 | 2019 | 52 | |
| 8 | 2014 | 50 | |
| 9 | 2014 | 46 | |
| 10 | 2009 | 43 | |
| 11 | 2014 | 40 | |
| 12 | 2014 | 36 | |
| 13 | 2018 | 36 | |
| 14 | 2017 | 33 | |
| 15 | 2008 | 32 | |
| 16 | 2018 | 29 | |
| 17 | 2019 | 28 | |
| 18 | 2012 | 26 | |
| 19 | 2019 | 26 | |
| 20 | 2013 | 25 |
About Lin Cheng
Lin Cheng is a scholar working on Molecular Biology, Cancer Research, Oncology, Health, Toxicology and Mutagenesis and Pathology and Forensic Medicine, having authored 70 papers that have together received 1.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Natural product bioactivities and synthesis (5 papers), Viral-associated cancers and disorders (4 papers), Bone Metabolism and Diseases (4 papers), Environmental Toxicology and Ecotoxicology (3 papers), Perovskite Materials and Applications (3 papers), RNA Research and Splicing (3 papers) and Plant Stress Responses and Tolerance (2 papers). The work is most often cited by research in Oncology (289 citations), Cancer Research (137 citations), Molecular Biology (605 citations), Virology (27 citations) and Health, Toxicology and Mutagenesis (66 citations). Lin Cheng has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Qiang Ding, Ellen Li, Chun Lu, Tiansong Xia, Liang Shi, Wenbin Zhou, Yulan Zhu, Yi Zeng, Zhigang Lv and Shuihong Yao. Their work appears in journals such as PLoS ONE, Bioscience Reports, BMC Cancer, Frontiers in Pharmacology and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.